The present review differentiates itself from prior studies through three principal innovations: (1) It provides a critical appraisal of current anti-obesity therapeutic strategies, identifying their pharmacological limitations and clinical shortcomings
Although they have not been associated with specific intestinal diseases, their high prevalence in foods and animal feeds as well as the increasing amount of evidence of their deleterious effects show that there is reason for concern
Optimizing Outcomes with Semaglutide and Tirzepatide Both semaglutide and tirzepatide represent powerful tools in the fight against type 2 diabetes and obesity
Always consult a licensed healthcare professional before starting any new supplement, especially if you are managing a health condition, pregnant, nursing, or taking medications
By accepting our use of cookies, your data will be aggregated with all other user data
We see many patients who underwent bariatric surgery years ago and have experienced weight regain